Antoon Santegoeds

Website of the past company as the current company has no business website.

3D Printing and Advanced Robotics

3D PARS brings together 3D printing and advanced robotics to create new biomedical products, services and applications for the benefit of all. 3D PARS directs the advancement of these new technologies in a comprehensive environment by providing consultation, development, service, testing, evaluation, training and education for a global market. From the idea to the bench, the prototype to the clinical trial, and the satellite lab to the classroom, 3D PARS is there! Dr. Mauris DeSilva created 3D PARS as a lean, flexible, and geographically responsive startup company with expertise in delivering biotech and research products and services to a wide array of customers in a variety of settings. By bringing scientists, technologists, engineers, policy makers, resource managers and educators together, Dr. DeSilva envisions 3D PARS as a facilitator for creative, innovative translational research in biotechnology, 3D printing and robotics. 3D PARS is also developing novel training and education programs geared to inform professionals and engage K-20 students and teachers.

Avacta Analytical

Avacta Analytical provided analytical contract research and innovative instrumentation to the biopharmaceutical sector before the sale of its business in 2015.

Experimmune

Experimmune is no longer in operation. Whether for contract purposes or third party validation, Experimmune offers full-scale laboratory support for all major phases of a customer’s immunological research and development. Since our expertise falls within the areas of immunodiagnostics and immunotherapeutics, we support services for pre-clinical animal models and human specimens that include but are not limited to: assay development, antigen discovery (B and T cell epitope characterization), and humoral/cell-mediated analysis. At Experimmune, we specifically tailor our methods to the goals of its customers. In addition to immunodiagnostic and immunotherapeutic development, we are able to offer a wide range of services. These services include pre-clinical in vitro and in vivo efficacy models for oncology as well as pharmacokinetic and immunogenicity studies utilizing your drug or drug carrier. Experimmune provides high-quality monoclonal and polyclonal antibody services for research purposes. We offer competitive packages for generating antibodies to protein and peptide targets against a range of species including mice and humans. Ultimately, our team will deliver exceptional one-on-one guidance in meeting the antibody needs of its customers.

BioMimOx Ltd

BioMimOx is an early stage biotech company investigating a proprietary peptide display platform for selection and affinity maturation of peptide aptamers and antibodies for use in research, diagnostics and biotherapeutics. We are also to investigate proprietary peptide aptamers and library construction as next generation affinity ligand binders.